Skip to content
Review

A review of recent developments of bio-polymers as combined biomedical platforms over the past decade

Jul 2026 · Polymer Bulletin · Vol 83 · 0 citations · 146 references

TL;DR

This review critically evaluates the design parameters of biopolymer delivery systems, focusing on the optimization of particle size and drug loading capacity and addresses key translational hurdles, including the biological limitations of active targeting and safety concerns like complement activation-related pseudoallergy.

View source

Similar papers

Review Aug 2026

A Comprehensive Review of Mesoporous Silica Nanoparticles in Drug Formulation: Synthesis, Characterization, and Applications.

Evidence from recent studies demonstrates that MSNs significantly improve drug loading efficiency, enhance solubility and bioavailability, and reduce off-target toxicity, Consequently, MSNs represent a highly versatile and modifiable platform with considerable potential for addressing the limitations of conventional dr...

Ahmad Ainurofiq, Y. Ramadhana, Salma Aqilah Rachmadani et al. · 0 citations
Review Open access Aug 2026

From nature to nanoscale: advances, challenges, and preclinical translation of nanofiber drug delivery systems containing plant-derived active ingredients.

This review offers a comprehensive overview of research on herbal drug-loaded nanofibers and contributes a novel perspective with regulatory and clinical translational insights.

H. Polat, Yasin Turanlı, Nihat Kurt et al. · 0 citations
Review Open access Aug 2026

A Comprehensive Review on Engineering Release at the Molecular Level: Role of Functional Groups in Polysaccharide-Based Drug Delivery

A sophisticated blueprint for the next generation of nature-derived, “intelligent” biomaterials in cancer therapy is provided, providing a sophisticated blueprint for the next generation of nature-derived, “intelligent” biomaterials in cancer therapy.

D. Crisan, T. Enache · 0 citations
Review Open access Jul 2026

From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery

Current trends of nanotechnology developments in the pharmaceutical market largely focus on the treatment of cancer, infectious diseases, central nervous system disorders and cardiovascular diseases, and lipid nanoparticle platforms are gaining relevance in current development pipelines.

Ronny Vargas, Fabiola Martos-Kikut, Noelia Martínez-Martínez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.